Latest Advances

  • Condition: Type 1 Hepatorenal Syndrome
  • Journal: The New England journal of medicine
  • Treatment Used: Terlipressin plus Albumin
  • Number of Patients: 300
  • Published —
The study researched the use of Terlipressin plus Albumin for treating type 1 hepatorenal syndrome.
  • Condition: Children with Liver Disease
  • Journal: BMC nephrology
  • Treatment Used: Trerlipressin
  • Number of Patients: 16
  • Published —
This study determined the safety and effectiveness of terlipressin in the treatment of children with liver disease.
  • Condition: Cirrhotic Patients with Ascites and without Hepatorenal Syndrome
  • Journal: Canadian journal of gastroenterology & hepatology
  • Treatment Used: Terlipressin
  • Number of Patients: 170
  • Published —
This review of the literature examined the use of terlipressin in patients with cirrhosis with ascites (fluid in abdomen) and without hepatorenal syndrome.
  • Condition: Deferasirox-Induced Liver Injury and Fanconi Syndrome in Male Patient with Beta-Thalassemia Major
  • Journal: BMJ case reports
  • Treatment Used: Cessation of Deferasirox
  • Number of Patients: 1
  • Published —
This case report discusses a Deferasirox-induced liver injury and Fanconi syndrome in a beta-thalassemia major male patient.
  • Condition: Type 1 Hepatorenal Syndrome in Alcohol-Related Acute on Chronic Liver Failure (AoCLF)
  • Journal: Medical science monitor : international medical journal of experimental and clinical research
  • Treatment Used: Molecular Adsorbent Recirculating System (MARS)
  • Number of Patients: 10
  • Published —
This study evaluated the effectiveness of the molecular adsorbent recirculating system (MARS) in patients with alcohol-related acute-on-chronic liver failure (AoCLF) complicated with type 1 hepatorenal syndrome (HRS).
  • Condition: Hepatorenal Syndrome
  • Journal: Alimentary pharmacology & therapeutics
  • Treatment Used: Terlipressin
  • Number of Patients: 203
  • Published —
In this study, researchers evaluated the outcomes of using terlipressin for the treatment of hepatorenal syndrome.
  • Condition: Decompensated Cirrhosis
  • Journal: Deutsche medizinische Wochenschrift (1946)
  • Treatment Used: Albumin
  • Number of Patients: 0
  • Published —
This study evaluated the use of albumin (a protein made by the liver) in patients with decompensated cirrhosis (advanced stage of cirrhosis, which is scarring in the liver).
  • Condition: Patients with Chronic Hepatitis B-Related Acute-On-Chronic Liver Failure (HBV-ACLF)
  • Journal: Hepatology international
  • Treatment Used: Plasma Perfusion Combined with Plasma Exchange (PP+PE)
  • Number of Patients: 988
  • Published —
This study evaluated the effectiveness of plasma perfusion combined with plasma exchange (PP?+?PE) in patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF).
  • Condition: Hereditary Tyrosinemia Type 1
  • Journal: Nutrients
  • Treatment Used: Natural Protein (NP)
  • Number of Patients: 31
  • Published —
This study assessed natural protein (NP) tolerance and metabolic control in patients with hereditary tyrosinemia type 1 (protein disorder; HTI).
  • Condition: Chronic Liver Failure and Acute Kidney Injury
  • Journal: Clinical nephrology
  • Treatment Used: Continuous Renal Replacement Therapy
  • Number of Patients: 66
  • Published —
This study reviewed the clinical outcomes of patients with acute kidney injury (AKI) and acute or chronic liver failure (ACLF) treated with continuous renal replacement therapy.
  • Condition: Ascites, Liver Cirrhosis
  • Journal: European journal of gastroenterology & hepatology
  • Treatment Used: Spironolactone and Eplerenone
  • Number of Patients: 105
  • Published —
This study compared the effectiveness and side effects of Spironolactone and Eplerenone for the treatment of ascites due to liver cirrhosis.
Showing 1-12 of 35